Volcano announces limited market release of SyncVision

320

Volcano Corporation has announced the commencement of limited market release of its US Food and Drug Administration (FDA) cleared and CE marked technology SyncVision, with cases being performed in the USA and Europe. SyncVision is currently installed in multiple limited market release sites throughout USA and Europe.  According to Volcano, the new system allows co-registration of angiography with intravascular ultrasound imaging.

Volcano’s SyncVision technology system is an on-line image processing workstation for coronary catheterisations that allows the physician to navigate simultaneously on an angiogram and on an IVUS image in a single correlated view using co-registration of the Eagle Eye platinum catheter with X-ray angiography. SyncVision is designed to bring the detailed vessel, lumen and wall structure from angiography and the spatial localisation of Volcano’s intravascular ultrasound images within the coronary tree together in a co-registered view to facilitate more informed treatment decisions and more efficient, enhanced workflow performance.

 


“SyncVision is an important advancement in clinical intravascular ultrasound imaging. It allows us to correlate significant intravascular ultrasound findings with the corresponding spots on the angiogram. This addresses a challenging aspect of current practice in that it can be difficult to identify the precise spot needing treatment in translating the intravascular ultrasound findings to the angiogram,” comments Steven Goldberg, director, Cardiac Catheterization Laboratory and clinical associate professor of medicine at University of Washington Medical Center. “It also allows for simple and precise length measurements to help inform stent selection. Co-registration of different imaging modalities is currently the wave in interventional cardiology, and I think this is one of the most useful and user friendly co-registration formats I have seen. I believe that this truly represents the next generation in intravascular ultrasound imaging.”

 


“The co-registration with angiography makes of intravascular ultrasound an entirely new instrument. As a regular intravascular ultrasound user, I was impressed to see how it helps in making decisions based on intracoronary imaging,” comments Javier Escaned, consultant interventional cardiologist, Hospital Clinico San Carlos.  “In addition, the angiographic tools incorporated in SyncVision are extremely helpful during coronary interventions. Image stabilisation and digital enhancement based not only on cine but also on images under fluoroscopy is a great complement of intravascular ultrasound in performing accurate stent optimisation without geometric mismatch. My impression is that with this system we move into an entirely new era of integration of intravascular ultrasound and angiography in clinical practice.”

 


According to Volcano, SyncVision is expected to be in full market release later in 2014.

(Visited 48 times, 1 visits today)